Literature DB >> 11173660

p53 protein accumulation and p53 gene mutation in colorectal cancer.

A Nasierowska-Guttmejer 1, L Trzeciak , M P Nowacki , J Ostrowski .   

Abstract

Comparison of immunohistochemical methods for detection of protein p53 accumulation and molecular techniques for analysis p53 gene mutation in colorectal cancer is presented. Thirty eight patients were included: all underwent surgery without preoperative treatment. Sex of patients, tumor localisation, macro and microscopic type of cancer and staging according to Astler-Coller and Jass classifications were evaluated. Protein p53 accumulation was detected by the streptavidin-biotin method using DO-7 (Dako) antibody. The number of cells stained were classified semiquanititatively according to a scoring system: (-)no positive cells, (+) : 10-30% positive cells, (++) : 40-70% positive cells, (+++) : >70% positive cells. For all cancer samples, exons 5 to 9 of p53 gene were amplified from isolated genomic DNA. PCR products were subjected to single standed conformational polymorphism analysis. All product were also directly sequenced on ABI PRISM 377 apparatus using fluorescent dideoxyterminators chemistry. The protein p53 accumulation was detected in 53% (20/38), whereas p53 gene mutation was seen in 55% (21/38). Among them, 15 patients (39%) with overexpression showed mutation in exon 5-8 gene p53. Discrepancies between results were noted in 29%. In conclusion, the necessity of both methods immunohistochemical and molecular is indicated for the objective evaluation of functional and structural status of p53 gene and protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11173660     DOI: 10.1007/bf03187331

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  26 in total

Review 1.  The p53 network.

Authors:  M L Agarwal; W R Taylor; M V Chernov; O B Chernova; G R Stark
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

Review 2.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

3.  Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer.

Authors:  T Caldes; P Iniesta; F J Vega; C de Juan; J A Lopez; E Diaz-Rubio; C Fernandez; J Cerdan; J L Balibrea; M Benito
Journal:  Oncology       Date:  1998 May-Jun       Impact factor: 2.935

4.  Tumor suppressor genes and the practice of surgical pathology.

Authors:  J Locker
Journal:  Hum Pathol       Date:  1995-04       Impact factor: 3.466

5.  p53 in tumour pathology: can we trust immunohistochemistry?--Revisited!

Authors:  P A Hall; D P Lane
Journal:  J Pathol       Date:  1994-01       Impact factor: 7.996

6.  Clinical significance of serum p53 antibody detection on chemosensitivity assay in human colorectal cancer.

Authors:  A Takeda; K Nakajima; H Shimada; H Imaseki; W Takayama; H Hayashi; T Suzuki; T Ochiai; K Isono
Journal:  J Surg Oncol       Date:  1999-06       Impact factor: 3.454

7.  Accumulation of p53 in relation to long-term prognosis in colorectal carcinoma.

Authors:  T Starzynska; M Bromley; K Marlicz; S A Roberts; M Ucinski; P L Stern
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-02       Impact factor: 2.566

Review 8.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

9.  Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.

Authors:  R J Slebos; I O Baas; M Clement; M Polak; J W Mulder; F M van den Berg; S R Hamilton; G J Offerhaus
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

10.  Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.

Authors:  B Dix; P Robbins; S Carrello; A House; B Iacopetta
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more
  4 in total

1.  p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.

Authors:  Peter F Rambau; Michael Odida; Henry Wabinga
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

2.  Novel molecular classification of colorectal cancer and correlation with survival.

Authors:  Fayaz Hussain Mangi; Tanweer Ahmed Shaikh; Daniele Soria; Ali Muhammad Waryah; Ikram Din Ujjan; Jawaid Naeem Qureshi; Binafsha Manzoor Syed
Journal:  Saudi J Biol Sci       Date:  2022-03-10       Impact factor: 4.052

3.  Foretinib (GSK1363089) induces p53-dependent apoptosis in endometrial cancer.

Authors:  Yuhei Kogata; Tomohito Tanaka; Yoshihiro J Ono; Masami Hayashi; Yoshito Terai; Masahide Ohmichi
Journal:  Oncotarget       Date:  2018-04-27

4.  Characterization and Prognostic Value of Mutations in Exons 5 and 6 of the p53 Gene in Patients with Colorectal Cancers in Central Iran.

Authors:  Rahim Golmohammadi; Mohammad J Namazi; Mehdi Nikbakht; Mohammad Salehi; Mohammad H Derakhshan
Journal:  Gut Liver       Date:  2013-04-09       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.